COM:SANTEN
Santen Pharmaceutical Co., Ltd
- Stock
Last Close
1,664.00
22/11 06:45
Market Cap
650.87B
Beta: -
Volume Today
1.48M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 26.89B - | 24.03B 10.64% | 53.37B 122.09% | 23.05B 56.81% | 35.26B 52.95% | 31.94B 9.41% | 21.71B 32.02% | 6.64B 69.40% | 27.19B 309.16% | -14.98B 155.11% | 26.64B 277.77% | |
depreciation and amortization | 3.93B - | 6.96B 77.23% | 9.34B 34.21% | 9.88B 5.83% | 10.90B 10.26% | 10.97B 0.67% | 16.57B 51.09% | 16.77B 1.18% | 17.05B 1.71% | 17.25B 1.14% | 18.18B 5.39% | |
deferred income tax | ||||||||||||
stock based compensation | ||||||||||||
change in working capital | -782M - | -6.21B 694.12% | -9.79B 57.57% | -10.23B 4.59% | -2.57B 74.90% | -6.31B 145.62% | -1.98B 68.68% | -21.48B 986.89% | 4.71B 121.91% | -5.06B 207.50% | 15.70B 410.36% | |
accounts receivables | -6.30B - | -3.05B 51.55% | -7.51B 146.04% | -1.97B 73.85% | -6.44B 227.89% | 18.38B 385.33% | ||||||
inventory | 1.65B - | -521M 131.58% | -5.39B 934.17% | -4.12B 23.53% | -1.44B 65.17% | -5B 248.43% | -981M 80.38% | -4.59B 367.89% | 5.38B 217.28% | -1.14B 121.25% | -1.37B 19.67% | |
accounts payables | 2.44B - | 717M 70.67% | 4.95B 590.10% | 2.49B 49.66% | 3.69B 48.09% | -2.38B 164.57% | ||||||
other working capital | -2.43B - | -5.69B 133.92% | -4.40B 22.71% | -6.11B 39.05% | -1.13B 81.45% | 2.55B 324.69% | 1.34B 47.33% | -14.32B 1,167.14% | -1.20B 91.60% | -1.16B 3.49% | 1.07B 191.99% | |
other non cash items | -4.08B - | 606M 114.86% | -30.40B 5,116.67% | -11.86B 60.99% | -745M 93.72% | -3.71B 397.72% | 3.64B 198.06% | 36.87B 914.08% | -2.91B 107.88% | 39.94B 1,473.93% | 33.86B 15.23% | |
net cash provided by operating activities | 25.96B - | 25.39B 2.20% | 22.52B 11.27% | 10.84B 51.86% | 42.84B 295.12% | 32.89B 23.22% | 39.95B 21.44% | 38.81B 2.85% | 46.04B 18.64% | 37.15B 19.32% | 72.65B 95.57% | |
investments in property plant and equipment | -66.44B - | -9.09B 86.32% | -9.50B 4.49% | -9.94B 4.60% | -8.33B 16.14% | -9.23B 10.74% | -23.80B 157.95% | -35.84B 50.57% | -24.59B 31.40% | -10.69B 56.54% | ||
acquisitions net | -62.81B - | -4.10B 93.48% | -19.06B 365.32% | -5.95B 68.77% | 1.48B 124.78% | -3.40B 330.78% | -29.18B 757.31% | -2.97B 89.83% | -3.47B 16.87% | -207M 94.03% | ||
purchases of investments | -4.82B - | -198M 95.90% | -2.23B 1,026.77% | -478M 78.57% | -565M 18.20% | -931M 64.78% | -398M 57.25% | -3.38B 750.25% | -1.07B 68.47% | -589M 44.80% | -508M 13.75% | |
sales maturities of investments | 2.93B - | 4.33B 47.83% | 2.70B 37.62% | 1.38B 48.83% | 2.88B 108.17% | 2.16B 25.11% | 3.50B 62.48% | 3.07B 12.36% | 3.87B 26.06% | 2.15B 44.47% | 4.13B 92.04% | |
other investing activites | -4.80B - | 63.41B 1,420.72% | 49.77B 21.51% | -542M 101.09% | 5.32B 1,081.00% | 2.70B 49.26% | 4.35B 61.30% | -54M 101.24% | 838M 1,651.85% | -279M 133.29% | 922M 430.47% | |
net cash used for investing activites | -6.69B - | -61.71B 821.86% | 37.05B 160.04% | -28.20B 176.11% | -8.26B 70.71% | -2.94B 64.46% | -5.17B 76.32% | -53.35B 931.01% | -35.17B 34.08% | -26.78B 23.86% | -6.14B 77.05% | |
debt repayment | -37.97B - | -15.13B 60.14% | -9.52B 37.06% | -8.32B 12.68% | -4.10B 50.72% | -500M 87.80% | -3B 500% | -20.46B 582% | -11.28B 44.88% | -2.11B 81.27% | ||
common stock issued | 3B - | 567M - | -1.38B 343.74% | -20.46B - | 12.23B 159.76% | |||||||
common stock repurchased | -6M - | -12.38B - | -1M 99.99% | -14.12B 1,412,300% | -22M 99.84% | -12M - | -26.01B 216,625% | -16.96B 34.78% | ||||
dividends paid | -8.25B - | -8.26B 0.21% | -9.92B 20.08% | -10.75B 8.34% | -10.56B 1.79% | -10.58B 0.20% | -10.38B 1.90% | -11.19B 7.79% | -11.99B 7.20% | -12.61B 5.11% | -11.88B 5.76% | |
other financing activites | 300M - | 75.19B 24,964.67% | 990M 98.68% | 998M 0.81% | 1.25B 24.75% | 128M 89.72% | -446M 448.44% | -2.50B 459.87% | 58.48B 2,442.13% | 445M 99.24% | 217M 51.24% | |
net cash used provided by financing activities | -7.95B - | 28.96B 464.14% | -24.07B 183.10% | -28.66B 19.08% | -17.63B 38.48% | -28.11B 59.42% | -12.73B 54.71% | -16.68B 31.08% | 5.56B 133.31% | -37.22B 769.79% | -34.03B 8.57% | |
effect of forex changes on cash | 1.29B - | 889M 31.03% | -1.64B 284.03% | -1.50B 8.25% | 48M 103.20% | -338M 804.17% | -1.41B 317.16% | 2.69B 290.78% | 3.69B 37.32% | 1.74B 52.92% | 4.21B 141.86% | |
net change in cash | 12.60B - | -6.47B 151.39% | 33.88B 623.25% | -47.52B 240.27% | 17.00B 135.78% | 1.51B 91.10% | 20.63B 1,263.78% | -28.54B 238.33% | 20.13B 170.51% | -25.11B 224.77% | 36.68B 246.07% | |
cash at beginning of period | 59.80B - | 72.40B 21.07% | 65.92B 8.94% | 99.80B 51.39% | 52.28B 47.61% | 69.28B 32.52% | 70.80B 2.18% | 91.43B 29.15% | 62.89B 31.22% | 83.01B 32.00% | 57.90B 30.25% | |
cash at end of period | 72.40B - | 65.92B 8.94% | 99.80B 51.39% | 52.28B 47.61% | 69.28B 32.52% | 70.80B 2.18% | 91.43B 29.15% | 62.89B 31.22% | 83.01B 32.00% | 57.90B 30.25% | 94.58B 63.35% | |
operating cash flow | 25.96B - | 25.39B 2.20% | 22.52B 11.27% | 10.84B 51.86% | 42.84B 295.12% | 32.89B 23.22% | 39.95B 21.44% | 38.81B 2.85% | 46.04B 18.64% | 37.15B 19.32% | 72.65B 95.57% | |
capital expenditure | -66.44B - | -9.09B 86.32% | -9.50B 4.49% | -9.94B 4.60% | -8.33B 16.14% | -9.23B 10.74% | -23.80B 157.95% | -35.84B 50.57% | -24.59B 31.40% | -10.69B 56.54% | ||
free cash flow | 25.96B - | -41.05B 258.16% | 13.43B 132.72% | 1.34B 90.00% | 32.91B 2,350.19% | 24.56B 25.36% | 30.72B 25.07% | 15.00B 51.16% | 10.20B 32.00% | 12.56B 23.10% | 61.96B 393.37% |
All numbers in (except ratios and percentages)